These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 15457508)

  • 1. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
    Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
    Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
    Crawford HC; Fingleton BM; Rudolph-Owen LA; Goss KJ; Rubinfeld B; Polakis P; Matrisian LM
    Oncogene; 1999 May; 18(18):2883-91. PubMed ID: 10362259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
    Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
    Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation.
    Daniels DL; Weis WI
    Nat Struct Mol Biol; 2005 Apr; 12(4):364-71. PubMed ID: 15768032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in responsiveness of human esophageal squamous cell carcinoma lines to epidermal growth factor for MMP-7 expression.
    Xu H; Tanimoto A; Murata Y; Kimura S; Wang KY; Sasaguri Y
    Int J Oncol; 2003 Aug; 23(2):469-76. PubMed ID: 12851697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.
    Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y
    Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
    Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
    Jung HC; Kim K
    Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
    Tetsu O; McCormick F
    Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.
    Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y
    Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transactivation of vimentin by beta-catenin in human breast cancer cells.
    Gilles C; Polette M; Mestdagt M; Nawrocki-Raby B; Ruggeri P; Birembaut P; Foidart JM
    Cancer Res; 2003 May; 63(10):2658-64. PubMed ID: 12750294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development.
    Schmidt M; Patterson M; Farrell E; Münsterberg A
    Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells.
    Marchenko ND; Marchenko GN; Weinreb RN; Lindsey JD; Kyshtoobayeva A; Crawford HC; Strongin AY
    Int J Biochem Cell Biol; 2004 May; 36(5):942-56. PubMed ID: 15006646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
    Asally M; Yoneda Y
    Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare activation of the TCF/beta-catenin pathway in ovarian cancer.
    Furlong MT; Morin PJ
    Gynecol Oncol; 2000 Apr; 77(1):97-104. PubMed ID: 10739697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hot spots in beta-catenin for interactions with LEF-1, conductin and APC.
    von Kries JP; Winbeck G; Asbrand C; Schwarz-Romond T; Sochnikova N; Dell'Oro A; Behrens J; Birchmeier W
    Nat Struct Biol; 2000 Sep; 7(9):800-7. PubMed ID: 10966653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratinocyte transcriptional regulation of the human c-Myc promoter occurs via a novel Lef/Tcf binding element distinct from neoplastic cells.
    Kolly C; Zakher A; Strauss C; Suter MM; Müller EJ
    FEBS Lett; 2007 May; 581(10):1969-76. PubMed ID: 17466981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation.
    Spychala J; Kitajewski J
    Exp Cell Res; 2004 Jun; 296(2):99-108. PubMed ID: 15149841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV; Fryer CJ; Jones KA
    Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.